Marie D Cornelius1, Nancy L Day. 1. Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, USA. mdc1@pitt.edu
Abstract
PURPOSE OF REVIEW: This paper reviews results from published, in press, and conference proceedings from 2007 and 2008 that link in-utero tobacco exposure to neurodevelopmental outcomes in exposed offspring. RECENT FINDINGS: Prenatal tobacco exposure (PTE) affected speech processing, levels of irritability and hypertonicity, attention levels, ability to self-regulate, need to be handled, and response to novelty preference in infants. In early childhood, PTE effects were mostly behavioral outcomes including activity and inattention and externalizing behaviors, including conduct disorder and antisocial behavior. In adolescents, PTE predicted increased attention deficit hyperactivity disorder, modulation of the cerebral cortex and white matter structure, and nicotine addiction. Several studies found moderating effects with PTE and genetic susceptibilities including dopamine transporter, serotonergic synaptic function, and monomine oxidase pathways. Other studies suggested that environmental and genetic factors might be more important than the direct teratological effects of PTE. SUMMARY: The majority of studies reviewed were prospective and tobacco exposure was quantified biologically. Most demonstrated a direct association between PTE and neurodevelopmental outcomes. More work is needed to examine multifactorial influences. Effects of PTE on the offspring appear to be moderated by genetic variability, neurobehavioral disinhibition, and sex.
PURPOSE OF REVIEW: This paper reviews results from published, in press, and conference proceedings from 2007 and 2008 that link in-utero tobacco exposure to neurodevelopmental outcomes in exposed offspring. RECENT FINDINGS: Prenatal tobacco exposure (PTE) affected speech processing, levels of irritability and hypertonicity, attention levels, ability to self-regulate, need to be handled, and response to novelty preference in infants. In early childhood, PTE effects were mostly behavioral outcomes including activity and inattention and externalizing behaviors, including conduct disorder and antisocial behavior. In adolescents, PTE predicted increased attention deficit hyperactivity disorder, modulation of the cerebral cortex and white matter structure, and nicotine addiction. Several studies found moderating effects with PTE and genetic susceptibilities including dopamine transporter, serotonergic synaptic function, and monomine oxidase pathways. Other studies suggested that environmental and genetic factors might be more important than the direct teratological effects of PTE. SUMMARY: The majority of studies reviewed were prospective and tobacco exposure was quantified biologically. Most demonstrated a direct association between PTE and neurodevelopmental outcomes. More work is needed to examine multifactorial influences. Effects of PTE on the offspring appear to be moderated by genetic variability, neurobehavioral disinhibition, and sex.
Authors: Amelia M Arria; Chris Derauf; Linda L Lagasse; Penny Grant; Rizwan Shah; Lynne Smith; William Haning; Marilyn Huestis; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry Lester Journal: Matern Child Health J Date: 2006-01-05
Authors: Theodore A Slotkin; Emiko A MacKillop; Charles L Rudder; Ian T Ryde; Charlotte A Tate; Frederic J Seidler Journal: Neuropsychopharmacology Date: 2006-10-18 Impact factor: 7.853
Authors: Laurie F Beck; Brian Morrow; Leslie E Lipscomb; Christopher H Johnson; Mary E Gaffield; Mary Rogers; Brenda Colley Gilbert Journal: MMWR Surveill Summ Date: 2002-04-26
Authors: Laura R Stroud; Rachel L Paster; Matthew S Goodwin; Edmond Shenassa; Stephen Buka; Raymond Niaura; Judy F Rosenblith; Lewis P Lipsitt Journal: Pediatrics Date: 2009-05 Impact factor: 7.124
Authors: Sandra A Wiebe; Kimberly Andrews Espy; Christian Stopp; Jennifer Respass; Peter Stewart; Travis R Jameson; David G Gilbert; Jodi I Huggenvik Journal: Dev Psychol Date: 2009-01
Authors: L S Wakschlag; E O Kistner; D S Pine; G Biesecker; K E Pickett; A D Skol; V Dukic; R J R Blair; B L Leventhal; N J Cox; J L Burns; K E Kasza; R J Wright; E H Cook Journal: Mol Psychiatry Date: 2009-03-03 Impact factor: 15.992
Authors: Maria G Motlagh; Denis G Sukhodolsky; Angeli Landeros-Weisenberger; Liliya Katsovich; Nancy Thompson; Lawrence Scahill; Robert A King; Bradley S Peterson; Robert T Schultz; James F Leckman Journal: J Atten Disord Date: 2010-07-08 Impact factor: 3.256
Authors: Tomasz Schneider; Nicholas Ilott; Giovana Brolese; Lisiane Bizarro; Philip J E Asherson; Ian P Stolerman Journal: Neuropsychopharmacology Date: 2011-02-02 Impact factor: 7.853
Authors: Logan G Spector; Sharon E Murphy; Katherine M Wickham; Bruce Lindgren; Anne M Joseph Journal: Pediatrics Date: 2014-05-12 Impact factor: 7.124
Authors: Shawn Bauldry; Michael J Shanahan; Ross Macmillan; Richard A Miech; Jason D Boardman; Danielle O Dean; Veronica Cole Journal: Soc Sci Res Date: 2016-03-03
Authors: Chris Derauf; Barry M Lester; Nurunisa Neyzi; Minal Kekatpure; Luis Gracia; James Davis; Kalpana Kallianpur; Jimmy T Efird; Barry Kosofsky Journal: Dev Neurosci Date: 2012-08-17 Impact factor: 2.984